.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Submacular hemorrhage management is critical for patients experiencing sudden and severe vision decline. This ophthalmic condition occurs when blood accumulates in the macular area between the neuroretina and the retinal pigment epithelium. Consequently, patients often notice a fixed, grayish-black scotoma in their central visual field. Therefore, clinicians must prioritize rapid diagnostic evaluation to prevent irreversible photoreceptor damage. Additionally, advanced multimodal imaging now provides essential support for determining the timing of adequate treatment.
Furthermore, various eye diseases like choroidal neovascularization in wet age-related macular degeneration frequently trigger these hemorrhages. However, systemic conditions such as hypertension also significantly influence the clinical course. Moreover, medications like antithrombotic drugs can exacerbate the severity of the subretinal bleed. Specifically, a holistic approach remains necessary to address these underlying factors while managing the acute ocular event.
The Manchester Protocol currently serves as a vital guideline for submacular hemorrhage management in modern clinical practice. In addition to conservative observation, this protocol outlines specific criteria for active intervention. For instance, if the hemorrhage exceeds the extent of two optic discs and occurs within two weeks, triple therapy becomes a viable option. This regimen involves the intravitreal injection of recombinant tissue plasminogen activator (rtPA), vascular endothelial growth factor (VEGF) inhibitors, and gas tamponade.
Thus, clinicians can effectively and safely displace the blood to allow for underlying retinal repair. Conversely, if triple therapy fails or if contraindications exist, surgical intervention like vitrectomy may become necessary. Ultimately, early and step-by-step intervention ensures the best possible functional outcomes and improves the patient's quality of life. Therefore, adhering to established protocols remains the cornerstone of successful therapy.
Patients typically report the sudden appearance of a fixed, grayish-black scotoma in their central field of vision, indicating macular involvement.
Triple therapy consists of intravitreal injections of rtPA to liquefy the clot, anti-VEGF agents to treat the underlying cause, and gas tamponade for pneumatic displacement.
Intervention should ideally occur within two weeks of symptom onset because prolonged blood exposure causes irreversible toxicity to the retinal photoreceptors.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Submacular hemorrhage is a vision-threatening condition often caused by wet AMD. Effective management relies on early intervention using the Manchester Protocol and triple therapy—rtPA, anti-VEGF, and gas—to displace blood and preserve central vision.
4 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
